| P2093 | author name string | Tuangporn Suthiphongchai | |
| | Warapen Treekitkarnmongkol | |
| P2860 | cites work | c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma | Q77581743 |
| | Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance | Q80775649 |
| | Worldwide trends in mortality from biliary tract malignancies | Q21093310 |
| | PI3K induced actin filament remodeling through Akt and p70S6K1: implication of essential role in cell migration | Q23924064 |
| | Identification of a region within the ErbB2/HER2 intracellular domain that is necessary for ligand-independent association | Q24297029 |
| | Detection of hepatocyte growth factor/scatter factor receptor (c-Met) in axillary drainage after operations for breast cancer using reverse transcriptase-polymerase chain reaction | Q24803522 |
| | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| | Receptor tyrosine kinase signalling as a target for cancer intervention strategies | Q28188287 |
| | A new therapeutic antibody masks ErbB2 to its partners | Q28257173 |
| | The concept of synthetic lethality in the context of anticancer therapy | Q28268061 |
| | Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma | Q28293076 |
| | The ErbB signaling network: receptor heterodimerization in development and cancer | Q29617919 |
| | Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue | Q30978459 |
| | Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion | Q33529782 |
| | Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer | Q33890758 |
| | The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis | Q34493341 |
| | Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene | Q34560337 |
| | Oncogene expression in cholangiocarcinoma and in normal hepatic development | Q34668400 |
| | Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). | Q35045355 |
| | FAT, E-cadherin, beta catenin, HER 2/neu, Ki67 immuno-expression, and histological grade in intrahepatic cholangiocarcinoma | Q35588892 |
| | Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers | Q36671789 |
| | HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. | Q37015151 |
| | Diagnosis and management of cholangiocarcinoma. | Q37140020 |
| | Her2-positive breast cancer: herceptin and beyond. | Q37330891 |
| | Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma | Q37351498 |
| | ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions | Q38455863 |
| | In vitro and in vivo anti-tumour effects of a humanised monoclonal antibody against c-erbB-2 product | Q39993985 |
| | Selective inhibition of ion transport mechanisms regulating intracellular pH reduces proliferation and induces apoptosis in cholangiocarcinoma cells. | Q40230690 |
| | Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway | Q40256045 |
| | Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells | Q40318308 |
| | Chemopreventive and therapeutic efficacy of orally active tyrosine kinase inhibitors in a transgenic mouse model of gallbladder carcinoma | Q40390223 |
| | Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells. | Q40456753 |
| | Antisense oligonucleotides specific for the HER2/neu oncogene inhibit the growth of human breast carcinoma cells that overexpress HER2/neu | Q41017774 |
| | Establishment and characterization of a cholangiocarcinoma cell line from a Thai patient with intrahepatic bile duct cancer | Q41655575 |
| | Prolonged survival of mice with human gastric cancer treated with an anti-c-ErbB-2 monoclonal antibody | Q41895244 |
| | Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification. | Q43607758 |
| | The expression of phospho-AKT, phospho-mTOR, and PTEN in extrahepatic cholangiocarcinoma. | Q46160697 |
| | c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma. | Q52122642 |
| | Gene amplification and protein overexpression of HER-2/neu in human extrahepatic cholangiocarcinoma as detected by chromogenic in situ hybridization and immunohistochemistry: its prognostic implication in node-positive patients. | Q53577314 |
| P433 | issue | 32 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cholangiocarcinoma | Q124292 |
| | intrahepatic bile duct | Q12233655 |
| | bile duct neoplasm | Q56014549 |
| P304 | page(s) | 4047-4054 | |
| P577 | publication date | 2010-08-01 | |
| | 2010-08-28 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | High expression of ErbB2 contributes to cholangiocarcinoma cell invasion and proliferation through AKT/p70S6K | |
| P478 | volume | 16 | |